Adaptive Biotechnologies Corporation announced that Tycho Peterson will depart the company as CFO. Kyle Piskel, the company's Principal Accounting Officer, will succeed Peterson as full-time CFO. Piskel served as the company's interim CFO from February to June 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +5.77% | +9.76% | -43.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.78% | 383M | |
-20.42% | 10.82B | |
+47.11% | 3.25B | |
-33.20% | 2.11B | |
-14.15% | 2.08B | |
-26.21% | 1.48B | |
+19.47% | 1.02B | |
-2.62% | 733M | |
-31.33% | 391M | |
+29.03% | 332M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Announces CFO Changes